Profile
| Metric | Value |
|---|---|
| Full Name | Novartis AG |
| Ticker | NYSE: NVS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | novartis.com |
| Employees | 75,883 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $145.00 | |
| Price, 1D Change | -0.08% | |
| Market Cap | $278B | |
| TTM Dividend Yield | 2.75% | |
| PE Ratio | 19.77 | |
| Beta | 0.22 | |
| Revenue | $50B | |
| Revenue, 1Y Change | +10.67% | |
| EPS | $5.86 | |
| EPS, 1Y Change | -17.38% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $3.99 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 279:250 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.86 | |
| EPS Estimate | $8.94 | |
| EPS Est. Change | +52.40% | |
| Revenue | $50.29B | |
| Revenue Estimate | $55.61B | |
| Revenue Est. Change | +10.59% | |
| Current Price | $145.00 | |
| Price Target | - | $138.00 |
| Price Tgt. Change | - | -4.83% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.66 | $7.10 | +6.58% | |
| $7.56 | $5.86 | -22.45% | |
| $8.94 | N/A | +52.40% | |
| $9.23 | N/A | +57.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $47.18B | $45.44B | -3.68% | |
| $50.41B | $50.29B | -0.24% | |
| $55.61B | N/A | +10.59% | |
| $57.03B | N/A | +13.41% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +44.96% | |
| Price, 3Y | +57.25% | |
| Market Cap, 1Y | +40.82% | |
| Market Cap, 3Y | +42.35% | |
| Revenue, 1Y | +10.67% | |
| Revenue, 3Y | -2.59% | |
| EPS, 1Y | -17.38% | |
| EPS, 3Y | -44.82% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $145.00 | |
| SMA 200 | $123.67 | |
| SMA 200 vs Price | -14.71% | |
| SMA 50 | $135.34 | |
| SMA 50 vs Price | -6.66% | |
| Beta | 0.22 | |
| ATR | $2.26 | |
| 14-Day RSI | 66.64 | |
| 10-Day Volatility | 21.43% | |
| 1-Year Volatility | 22.09% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $3.99 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.58% | |
| Total Dividend | $3.74 | |
| Dividends Paid | $7.62B | |
| Payout Ratio | 63.86% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $50.29B | |
| EPS | $5.86 | |
| Gross Profit | $37.48B | |
| Gross Margin | 74.53% | |
| Operating Profit | $15.42B | |
| Operating Margin | 5.19% | |
| Net Income | $11.93B | |
| Net Margin | 23.73% | |
| EBITDA | $21.48B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.71 | |
| Current Ratio | 1.04 | |
| Quick Ratio | 0.84 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 4.23 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 19.77 | |
| PS Ratio | 5.11 | |
| PB Ratio | 6.28 | |
| EV/EBITDA | 13.36 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $44.05B | |
| Cash & Equivalents | $13.46B | |
| Total Assets | $106.76B | |
| Current Assets | $29.70B | |
| Total Liabilities | $62.64B | |
| Current Liabilities | $28.69B | |
| Total Debt | $31.26B | |
| Short Term Debt | $8.32B | |
| Accounts Payable | $4.57B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $38.35B | |
| Operating Expenses | $22.06B | |
| Cost Of Goods Sold | $12.81B | |
| SG&A | $0.00 | |
| D&A | $6.07B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.70B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $17.61B | |
| CFI | -$7.51B | |
| CFF | -$11.74B | |
| Capex | $3.81B | |
| Free Cash Flow | $13.80B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| JP Morgan | → | |
| Goldman Sachs | → | |
| UBS | → | |
| Erste Group | → | |
| BMO Capital | → | |
| B of A Securities | → | |
| Goldman Sachs | → | |
| Jefferies | → | |
| Jefferies | → |
Analyst sentiment
Institutional ownership
Screeners with NVS
FAQ
What is the ticker symbol for Novartis AG?
The ticker symbol for Novartis AG is NYSE:NVS
Does Novartis AG pay dividends?
Yes, Novartis AG pays dividends. The last payment was $3.99, with an ex-dividend date on March 12, 2025
What sector is Novartis AG in?
Novartis AG is in the Healthcare sector
What industry is Novartis AG in?
Novartis AG is in the General Drug Manufacturers industry
What country is Novartis AG based in?
Novartis AG is headquartered in Switzerland
When did Novartis AG go public?
Novartis AG initial public offering (IPO) was on November 7, 1996
Is Novartis AG in the S&P 500?
No, Novartis AG is not included in the S&P 500 index
Is Novartis AG in the NASDAQ 100?
No, Novartis AG is not included in the NASDAQ 100 index
Is Novartis AG in the Dow Jones?
No, Novartis AG is not included in the Dow Jones index
When was Novartis AG last earnings report?
Novartis AG's most recent earnings report was on October 28, 2025
When does Novartis AG report earnings?
The next expected earnings date for Novartis AG is February 4, 2026
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1114448/000111444825000003/0001114448-25-000003-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000137036825000004/0001370368-25-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs